Valeant directors, CEO ordered to cease trading shares
March 31 (Reuters) - Valeant Pharmaceuticals International Inc's directors and key officers have received a cease-trade order by the securities regulator in the Canadian province of Quebec, on the company's request, Valeant said on Thursday.
In a separate statement, the Autorité Des Marches Financiers said the order takes effect Thursday and is in place for 15 days. (Reporting by Rod Nickel in Winnipeg, Manitoba)
© Thomson Reuters 2017 All rights reserved.